SC
Suvretta Capital
Suvretta Capital is a Series A to Series D stage investment firm. It has made 6 investments. Their most common stage is series-d (43% of deals). Average disclosed round size is $143.4M (across 7 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series D
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Avalyn Pharma, Inc. | Series D | $100M | Jul 2025 |
| AAvalyn | Series C | $100M | Sep 2023 |
| AAmbrx Inc | Unknown | $45M | Nov 2020 |
| BBioshin | Series A | $60M | Sep 2020 |
 VeraDermics | Series B | $75M | — |
 Turntide Technologies | Series D | $524M | — |
| AAvalyn | Series D | $100M | — |
Top Co-Investors
Surveyor Capital4 shared
F-Prime Capital3 shared
SR One3 shared
Pivotal Life Sciences3 shared
Catalio Capital Management2 shared
Wellington Management2 shared
RiverVest Venture Partners2 shared
Eventide Asset Management2 shared
T. Rowe Price2 shared
Novo Holdings A/S2 shared
Rock Springs Capital2 shared
Norwest Venture Partners2 shared
HBM Healthcare Investments2 shared
TPG Biotech1 shared
Maverick Ventures1 shared
Adage Capital Management1 shared
Apricot Capital1 shared
Hopu Investments1 shared
Last updated: 20 October 2026